Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$0.28 - $1.16 $16 - $69
-60 Reduced 0.36%
16,447 $5,000
Q1 2024

May 08, 2024

BUY
$1.06 - $1.67 $816 - $1,285
770 Added 4.89%
16,507 $19,000
Q1 2023

May 01, 2023

SELL
$1.2 - $2.19 $50,176 - $91,572
-41,814 Reduced 72.66%
15,737 $20,000
Q4 2022

Feb 03, 2023

BUY
$1.63 - $3.52 $93,808 - $202,579
57,551 New
57,551 $97,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.